Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Izrael, Tel Awiw
Ofer Merimsky
41 lat doświadczenia
akredytacje :
Akredytacje :
Small intestine cancer treatment cost in Israel typically involves diagnostic imaging like PET-CT ranging from $1,300 to $1,800 and specialized procedures like Hyperthermic Intraperitoneal Chemotherapy (HIPEC) which runs from $61,200 to $95,900. Total expenses depend on the cancer stage, surgical complexity, and specific medication protocols. Patients often save approximately 20-40% compared to the United States. Top treatment centers are located in Tel Aviv, Jerusalem, and Haifa.
Typical Small Intestine Cancer Treatment Costs in Israel
Bookimed Expert Insight: Patients with advanced abdominal involvement should consider Sourasky Medical Center for HIPEC and Whipple surgery. This facility reports a 90% average success rate for oncology treatments. For complex surgical needs, Assuta Medical Center offers private care with 92,000 annual operations. International patients benefit from centers like Hadassah, where Forbes-listed specialists provide multidisciplinary care for rare gastrointestinal malignancies.
| Izrael | Turcja | Austria | |
| Hipec (Hipertermiczna Chemioterapia Dootrzewnowa) | od $61,200 | od $22,500 | od $40,000 |
| Chemioterapia w raku piersi | od $22,500 | od $1,200 | od $15,000 |
| Resekcja jelita cienkiego | - | od $12,150 | od $25,000 |
| Radioterapia w raku jelita | - | od $5,800 | od $7,023 |
| Radioterapia raka odbytnicy | - | od $7,000 | od $12,000 |
Prof. Merimsky kieruje Oddziałem Onkologii Tkanek Miękkich i Kości w Centrum Medycznym Sourasky. Specjalizuje się w rzadkich nowotworach, takich jak rak jelita cienkiego.
Dr Pelles Sharon specjalizuje się w zaawansowanych metodach leczenia nowotworów, w tym raka jelita cienkiego, w Centrum Medycznym Sourasky (Ichilov).
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.
He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.
Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.